MIR-23 blunts the expression of multiple key cytotoxic T-lymphocyte (CTL) effector molecules, including IFN-γ, thereby suppressing T-cell-mediated cytotoxicity and, subsequently, accelerating tumor progression and increasing the tumor burden [117]. This evidence concerns the gene IFNG and neoplasm.